Company intelligence / Profile preview

Aindra Systems

Bengaluru, Karnataka, Indiaaindra.in ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

Aindra Systems has developed and commercialized an AI-driven point-of-care diagnostic system—CervAstra—for rapid cervical cancer screening. The company’s integrated hardware-software platforms enable affordable, accessible diagnostics with high accuracy. Clinical results have demonstrated the ability to deliver quick turnaround times and reliable detection at primary health centers. Expansion into additional oncology indications and geographies is planned.

Therapeutic areas: Oncology
Modalities: Device (AI-powered diagnostic devices)Software (AI/ML algorithms for pathology)Non-pharmacological therapy (diagnostic platform)
Industry: Pathology

Partnerships

India-Sweden Healthcare Innovation Centrelocal channel partners in South/Southeast Asia planned for market entry

Beyond the preview

Go deeper on Aindra Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aindra Systems.

Explore the full profile